Asia Pacific connected healthcare device market will grow by 21.1% annually with a total addressable market cap of $495.3 billion over 2024-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetration of mobile and internet technology, government initiatives, growing spending on R&D activities, and an increasing adoption of IT and IoT in healthcare.
Highlighted with 33 tables and 61 figures, this 133-page report “Asia Pacific Connected Healthcare Device Market 2023-2033 by Product (Medical Devices, Wellness Devices, Software & Services), Device Type (Wearable, Implantable, Stationary), Application (Remote Monitoring, Consultation and Diagnosis, Treatment, Fitness and Wellness), End User (Hospitals, Clinics, ASCs, Home Care), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific connected healthcare device market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific connected healthcare device market in every aspect of the classification from perspectives of Product, Device Type, Application, End User, and Country.
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
- Medical Devices
o Blood Pressure Monitor
o Glucose Monitor
o Insulin Pump
o ECG Monitoring Device
o Pulse Oximeter
o Portable GPS PERS
o Smart Pill Dispenser
o Other Medical Devices
- Wellness Devices
o Body Analyzer
o Digital Pedometer
o GPS Sports Watch
o Heart Rate Monitor
o Sleep Quality Monitor
o Other Wellness Devices
- Software & Services
o Fitness & Wellness App
o Online Subscription
o Other Software & Services
Based on Device Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
- Wearable Devices
- Implantable Devices
- Stationary Devices
By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
- Remote Monitoring
- Consultation and Diagnosis Services
- Treatment Services
- Fitness and Wellness Services
By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers (ASCs)
- Home Care Settings
- Other End Users
Geographically, the following national/local markets are fully investigated:
- Japan
- China
- South Korea
- Australia
- India
- Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2023-2033. The breakdown of national markets by Product, Device Type, and End User and Application over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Aerotel Medical System Ltd.
AgaMatrix, Inc.
Apple Inc.
BioTelemetry Inc.
Biotronik SE & Co. KG
Boston Scientific Corporation
DexCom Inc.
Draeger Medical Systems, Inc.
F. Hoffmann-La Roche AG
Fitbit, Inc.
Garmin Ltd.
GE Healthcare
Honeywell International Inc.
IHealth Labs (Subsidiary of Andon Health)
Johnson & Johnson
Koninklijke Philips NV
McKesson Corporation
Medtronic PLC
NXP Semiconductors NV
Omron Healthcare Inc.
Phillips Healthcare Company
Siemens Healthcare Private Limited
Stanley Healthcare
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)